<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000386214"><TermName>gimatecan</TermName><TermPronunciation>(jih-muh-TEE-kan)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called topoisomerase inhibitors. Also called ST1481.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000731482" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;gimatecan&quot;" language="en" id="_3"/><MediaLink ref="CDR0000731483" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;gimatecán&quot;" language="es" id="_4"/><SpanishTermName>gimatecán</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Es un tipo de inhibidor de la topoisomerasa. También se llama ST1481.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2004-08-24</DateFirstPublished><DateLastModified>2004-10-22</DateLastModified></GlossaryTerm>
